今天 ASCO 發佈一些訊息, 贊助者包含不少知名藥商, 這些藥商應該都看過實驗結果吧?
Randomized phase II/III trial of active immunotherapy with OPT-822/OPT-821 in patients with metastatic breast cancer.
Chiun-Sheng Huang
Employment - No Relationships to Disclose
Leadership - No Relationships to Disclose
Stock and Other Ownership Interests - No Relationships to Disclose
Honoraria - Novartis; Roche
Consulting or Advisory Role - Roche
Speakers’ Bureau - No Relationships to Disclose
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - No Relationships to Disclose
Expert Testimony - No Relationships to Disclose
Travel, Accommodations, Expenses - No Relationships to Disclose
Other Relationship - No Relationships to Disclose
